60 related articles for article (PubMed ID: 24477173)
41. Telomerase and the process of cervical carcinogenesis.
Nachajova M; Brany D; Dvorska D
Tumour Biol; 2015 Sep; 36(10):7335-8. PubMed ID: 26318433
[TBL] [Abstract][Full Text] [Related]
42. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
[TBL] [Abstract][Full Text] [Related]
43. Human telomerase RNA gene amplification detection increases the specificity of cervical intraepithelial neoplasia screening.
Zheng L; Liu AL; Qi T; Wang Q; Cai Z; Su YJ; Hu YW; Liu GB; Wei LH
Int J Gynecol Cancer; 2010 Aug; 20(6):912-7. PubMed ID: 20683395
[TBL] [Abstract][Full Text] [Related]
44. Genomic amplification patterns of human telomerase RNA gene and C-MYC in liquid-based cytological specimens used for the detection of high-grade cervical intraepithelial neoplasia.
Chen S; Yang Z; Zhang Y; Qiao Y; Cui B; Zhang Y; Kong B
Diagn Pathol; 2012 Apr; 7():40. PubMed ID: 22500694
[TBL] [Abstract][Full Text] [Related]
45. [Clinical application of telomerase RNA component gene amplification assay in cervical lesions.].
Jiang J; Wei LH; Wu RF; Zhang G; Wulan N; Li JR; Li YB; Tu Z; Zhou YQ; Zhao Y; Chen Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Dec; 44(12):883-6. PubMed ID: 20193412
[TBL] [Abstract][Full Text] [Related]
46. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
47. Fluorescence in situ hybridization testing for the diagnosis of high-grade cervical abnormalities: a systematic review.
Earley A; Lamont JL; Dahabreh IJ; Cowan J; Feldman S; Uhlig K
J Low Genit Tract Dis; 2014 Jul; 18(3):218-27. PubMed ID: 24477173
[TBL] [Abstract][Full Text] [Related]
48. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.
Arbyn M; Ronco G; Anttila A; Meijer CJ; Poljak M; Ogilvie G; Koliopoulos G; Naucler P; Sankaranarayanan R; Peto J
Vaccine; 2012 Nov; 30 Suppl 5():F88-99. PubMed ID: 23199969
[TBL] [Abstract][Full Text] [Related]
49.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
50.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
51.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
52.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
